Confluence Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Sell
94,086
-5,759
-6% -$1.19M 0.29% 87
2026
Q1
$22.4M Sell
99,845
-6,551
-6% -$1.63M 0.35% 77
2025
Q4
$25.6M Sell
106,396
-4,262
-4% -$1.09M 0.38% 69
2025
Q3
$30.3M Sell
110,658
-4,405
-4% -$1.2M 0.43% 63
2025
Q2
$29.7M Sell
115,063
-3,532
-3% -$843K 0.42% 67
2025
Q1
$26.5M Sell
118,595
-5,169
-4% -$1.21M 0.38% 69
2024
Q4
$28.3M Sell
123,764
-3,100
-2% -$746K 0.39% 65
2024
Q3
$31M Sell
126,864
-1,868
-1% -$417K 0.41% 67
2024
Q2
$24.6M Sell
128,732
-429
-0.3% -$87K 0.36% 70
2024
Q1
$25.6M Buy
+129,161
New +$23.7M 0.34% 74

Other funds holding RMD

Confluence Investment Management's RMD Position: Q2 2026 in Review

Confluence Investment Management reduced its ResMed (RMD) stake by 5.8% in Q2 2026, selling an estimated $1.19M and leaving 94,086 shares worth $18.3M. The position accounts for 0.29% of the portfolio, ranked #87.

Confluence Investment Management first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $31M in Q3 2024. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Confluence Investment Management held 94,086 shares of ResMed worth $18.3M as of Q2 2026.
  • Confluence Investment Management sold 5,759 ResMed shares in Q2 2026, an estimated $1.19M.
  • ResMed made up 0.29% of Confluence Investment Management's portfolio in Q2 2026, its #87 holding.
  • Confluence Investment Management first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Confluence Investment Management's ResMed position peaked at $31M in Q3 2024.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Confluence Investment Management's 13F filing for Q2 2026, filed 1 Jul 2026.